Stock Events

Stock Events

Eupraxia Pharmaceuticals (X43.F) Q2 2026 Keputusan kewangan

X43.F
12MayDisahkan
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.21
-0.19
-0.17
-0.15

Butiran

EPS dijangka
-0.1603570370047416
EPS sebenar
-0.1909710318043764
EPS mengejut
-0.03
Peratus kejutan
+19.09%

Deskripsi

Eupraxia Pharmaceuticals (X43.F) telah melaporkan pendapatan sebanyak -0.1909710318043764 sesaham untuk Q2 2026.

0 Comments

Kongsi pendapat anda